Effects of Age and Infertility on Ovarian Granulosa Cell Function
Mechanistic Insight Into Ovarian Granulosa Cell Function Based on Age and Cause of Infertility
1 other identifier
observational
500
0 countries
N/A
Brief Summary
Infertility is a life changing disorder, affecting 1 in 7 couples within the UK. Treatment options pose a significant cost burden to both the NHS and patient when NHS-funded treatment options are exhausted. This highlights the need for refinements in clinical management strategies for this patient group. Although there have been advancements in assisted reproductive technologies, the success rates of techniques such as in vitro fertilization (IVF) remain low. Surprisingly, the IVF hormonal regimens used by most assisted conception units fail to take account of patient age, ovarian reserve or cause of infertility when deciding on treatment regimen, with a 'one size fits all' approach to treatment. The investigators propose that age and cause of infertility modify the functions and environment provided by the cells (granulosa cells) that support egg (oocyte) growth and development and understanding these changes will allow for a more personalised approach to IVF treatment regimens. The aim of this study therefore is to recruit female patients undergoing IVF with different causes of infertility and age, and harvest granulosa cells from remaining material (follicular aspirates) generated at the time of egg retrieval. Granulosa cells will be cultured in vitro and cellular functions assessed. The investigators will also recruit female patients with normal fertility undergoing IVF procedure due to other reasons (i.e. egg freezing, diagnostics of genetic diseases on embryos).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2021
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 25, 2021
CompletedFirst Posted
Study publicly available on registry
June 30, 2021
CompletedStudy Start
First participant enrolled
July 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedJuly 7, 2021
June 1, 2021
3 years
June 25, 2021
July 1, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of hormone production, protein and RNA expression
Assessed via cellular signalling responses to endocrine stimulation, production of steroid hormones, protein analysis and RNA analysis
0-14 days
Secondary Outcomes (1)
Correlation of cellular responses with age and cause of infertility.
12 months
Study Arms (11)
Women aged <30
Women aged 30-36
Women aged 37-40
Women aged >40
Women undergoing egg freezing/male factor infertility/genetic testing
unidentified cause of infertility
PCOS
endometriosis
tubal disorders
ovulatory disorders
other causes of infertility e.g., fibroids.
Eligibility Criteria
Women undergoing routine IVF treatment as part of their clinical treatment plan.
You may qualify if:
- Any woman that is:
- fluent in English,
- capable of giving consent,
- reproductive age (between the ages of 18-45),
- is HIV and Hep A and Hep B negative.
- undergoing IVF treatment for one of the following reasons:
- unexplained infertility
- tubal disease
- egg freezing
- polycystic ovarian syndrome
- ovulatory disorders
- endometriosis
- male factor infertility
- any other cause of infertility such as fibroids.
You may not qualify if:
- Adults unable to consent for themselves,
- Non-fluent English speakers, unless in clinic translators are available
- Aged less than 18
- Is HIV or Hep A or B positive, or has not undergone screening.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 25, 2021
First Posted
June 30, 2021
Study Start
July 1, 2021
Primary Completion
July 1, 2024
Study Completion
June 1, 2025
Last Updated
July 7, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share